159 related articles for article (PubMed ID: 8372199)
1. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging.
Maeda M; Itoh S; Kimura H; Iwasaki T; Hayashi N; Yamamoto K; Ishii Y; Kubota T
Radiology; 1993 Oct; 189(1):233-8. PubMed ID: 8372199
[TBL] [Abstract][Full Text] [Related]
2. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging.
Wenz F; Rempp K; Hess T; Debus J; Brix G; Engenhart R; Knopp MV; van Kaick G; Wannenmacher M
AJR Am J Roentgenol; 1996 Jan; 166(1):187-93. PubMed ID: 8571873
[TBL] [Abstract][Full Text] [Related]
3. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
[TBL] [Abstract][Full Text] [Related]
4. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
Warmuth C; Gunther M; Zimmer C
Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
[TBL] [Abstract][Full Text] [Related]
5. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
Strouse PJ; Prince MR; Chenevert TL
Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
[TBL] [Abstract][Full Text] [Related]
6. Vascularity of meningiomas and neuromas: assessment with dynamic susceptibility-contrast MR imaging.
Maeda M; Itoh S; Kimura H; Iwasaki T; Hayashi N; Yamamoto K; Ishii Y; Kubota T
AJR Am J Roentgenol; 1994 Jul; 163(1):181-6. PubMed ID: 8010210
[TBL] [Abstract][Full Text] [Related]
7. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP
Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
[TBL] [Abstract][Full Text] [Related]
8. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
Hirano Y; Kubo K; Hirai Y; Okada S; Yamada K; Sawano S; Yamashita T; Hiramatsu Y
Radiographics; 1992 Mar; 12(2):243-56. PubMed ID: 1561414
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of pancreatic transplant dysfunction: value of gadopentetate dimeglumine-enhanced MR imaging.
Fernandez MP; Bernardino ME; Neylan JF; Olson RA
AJR Am J Roentgenol; 1991 Jun; 156(6):1171-6. PubMed ID: 2028861
[TBL] [Abstract][Full Text] [Related]
10. Acute stroke in cats: comparison of dynamic susceptibility-contrast MR imaging with T2- and diffusion-weighted MR imaging.
Maeda M; Itoh S; Ide H; Matsuda T; Kobayashi H; Kubota T; Ishii Y
Radiology; 1993 Oct; 189(1):227-32. PubMed ID: 8372198
[TBL] [Abstract][Full Text] [Related]
11. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
Mihara F; Gupta KL; Righi AM
Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
[TBL] [Abstract][Full Text] [Related]
12. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
13. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
15. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
Giesel FL; Mehndiratta A; Risse F; Rius M; Zechmann CM; von Tengg-Kobligk H; Gerigk L; Kauczor HU; Politi M; Essig M; Griffiths PD; Wilkinson ID
Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867
[TBL] [Abstract][Full Text] [Related]
16. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression.
Semelka RC; Cumming MJ; Shoenut JP; Magro CM; Yaffe CS; Kroeker MA; Greenberg HM
Radiology; 1993 Mar; 186(3):799-802. PubMed ID: 8381551
[TBL] [Abstract][Full Text] [Related]
17. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol.
Yuh WT; Fisher DJ; Engelken JD; Greene GM; Sato Y; Ryals TJ; Crain MR; Ehrhardt JC
Radiology; 1991 Aug; 180(2):485-91. PubMed ID: 2068317
[TBL] [Abstract][Full Text] [Related]
18. [Contrast medium assisted nuclear magnetic resonance tomography. Signal intensity of gliomatous tumors].
Agnoli AL; Herrmann S
Rontgenblatter; 1990 Aug; 43(8):335-40. PubMed ID: 2399417
[TBL] [Abstract][Full Text] [Related]
19. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
Peterson MS; Baron RL; Murakami T
Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
[TBL] [Abstract][Full Text] [Related]
20. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
